PropertyEU

Oxford Properties kicks off €1.4b European life sciences strategy with Cambridge AstraZeneca HQ

By Virna Asara 2021-05-28T00:00:00

image

Oxford Properties, the property arm of Canadian pension fund giant OMERS, has expanded its life sciences platform with its first European acquisition involving the AstraZeneca headquarters in Cambridge, UK.

You have now reached your article limit

Already have an IPE Real Assets account? Sign in

PropertyEU has merged with IPE Real Assets

If you had a PropertyEU account, simply reset your password to get access to IPE Real Assets.

New users can Register for free today for access to the PropertyEU Archive and IPE Real Assets.

Register today

Registration also includes access to IPE

Gated access promo

Five reasons to register today

  1. Access IPE Real Assets articles
  2. Daily news alerts and updates
  3. Track what the world’s leading institutional investors are doing
  4. Learn about the latest industry research and market analysis
  5. Comprehensive archive of data and intelligence on investors and fund managers, including the PropertyEU Archive
SEE HOW IPE REAL ASSETS CAN HELP YOUR business